Burcher E, Warner F J
School of Physiology and Pharmacology, University of New South Wales, Kensington, Australia.
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jun;357(6):692-700. doi: 10.1007/pl00005226.
In this study, we have used radioligand binding and functional techniques to investigate tachykinin receptors in the small intestine of the cane toad Bufo marinus. The radioligand [125I]Bolton-Hunter [Sar9,Met(O2)11]substance P (selective at mammalian NK-1 receptors) showed no specific binding. Specific binding of [125I]Bolton-Hunter substance P ([125I]BHSP) was saturable, of high affinity (Kd 0.3 nM) and was inhibited by SP (IC50 0.64 nM) > ranakinin approximately neurokinin A (NKA) > or = SP(5-11) > or = neuropeptide gamma > or = scyliorhinin II > scyliorhinin I > or = [Sar9]-SP > or = neurokinin B approximately physalaemin approximately carassin >> SP(7-11) approximately eledoisin > or = SP(4-11) approximately SP(6-11). Binding was also inhibited by Gpp[NH]p > or = GTPgammaS > App[NH]p, indicating a G-protein coupled receptor. The order of potency of tachykinins and analogues in contracting the isolated lower small intestine was carassin (EC50 1.4 nM) > eledoisin approximately SP > or = physalaemin > or = ranakinin > SP(6-11) > scyliorhinin II > or = neuropeptide gamma > neurokinin B approximately NKA approximately scyliorhinin I > or = SP(4-11) > or = SP(5-11) > [Sar9]SP > SP(7-11). In both studies, the selective mammalian NK-1, NK-2 and NK-3 receptor agonists [Sar9,Met(O2)11]SP, [Lys5,Me-Leu9,Nle10]NKA(4-10) and senktide were weak or ineffective. There was a strong positive correlation between the pD2 and pIC50 values for mammalian tachykinins and analogues (r = 0.907), but not for the non-mammalian tachykinins, which were all full agonists but variable binding competitors. [Sar9,Met(O2)11]-SP(pD2 5.7) was approximately 25-fold less potent as an agonist than [Sar9]SP, which was itself 25-fold weaker than SP. Responses to SP were significantly reduced (n = 8, P<0.001) by the antagonist [D-Arg1,D-Trp7,9,Leu11]-SP (spantide; 1 microM). Highly selective NK-1 receptor antagonists including CP 99994 and GR 82334 (both 1 microM) were ineffective in both functional and binding studies. Tetrodotoxin (1 microM) did not inhibit contractile responses to SP, NKA and senktide. In summary, this study has shown the presence of one or more tachykinin receptor in the toad intestine. The binding site recognised by [125I]BHSP prefers SP and ranakinin. This toad "NK-1-like receptor" differs from the mammalian NK-1 receptor in having a low affinity for all mammalian NK-1 selective ligands, including antagonists. For some non-mammalian peptides, their high potency as contractile agonists relative to their poor binding affinity suggests the existence of other tachykinin receptors in the toad small intestine.
在本研究中,我们运用放射性配体结合和功能技术来研究海蟾蜍(Bufo marinus)小肠中的速激肽受体。放射性配体[125I]博尔顿 - 亨特[Sar9,Met(O2)11]P物质(对哺乳动物NK - 1受体具有选择性)未显示出特异性结合。[125I]博尔顿 - 亨特P物质([125I]BHSP)的特异性结合具有饱和性、高亲和力(解离常数Kd为0.3 nM),并且被P物质(半数抑制浓度IC50为0.64 nM)> ranakinin > 近似神经激肽A(NKA)> 或 = P物质(5 - 11)> 或 = 神经肽γ > 或 = 鲨肌肽II > 鲨肌肽I > 或 = [Sar9] - P物质 > 或 = 神经激肽B > 近似 physalaemin > 近似 肌动蛋白 >> P物质(7 - 11)> 或 = eledoisin > 或 = P物质(4 - 11)> 近似 P物质(6 - 11)所抑制。Gpp[NH]p > 或 = GTPγS > App[NH]p也能抑制结合,表明这是一种G蛋白偶联受体。速激肽及其类似物在收缩离体小肠下段时的效价顺序为:肌动蛋白(半数有效浓度EC50为1.4 nM)> eledoisin > 近似 P物质 > 或 = physalaemin > 或 = ranakinin > P物质(6 - 11)> 鲨肌肽II > 或 = 神经肽γ > 神经激肽B > 近似 NKA > 近似 鲨肌肽I > 或 = P物质(4 - 11)> 或 = P物质(5 - 11)> [Sar9]P物质 > P物质(7 - 11)。在这两项研究中,选择性的哺乳动物NK - 1、NK - 2和NK - 3受体激动剂[Sar9,Met(O2)11]P物质、[Lys5,Me - Leu9,Nle10]NKA(4 - 10)和senktide作用较弱或无效。哺乳动物速激肽及其类似物的pD2和pIC50值之间存在强正相关(r = 0.907),但非哺乳动物速激肽不存在这种相关性,它们都是完全激动剂,但作为结合竞争剂时活性不同。[Sar9,Met(O2)11] - P物质(pD2为5.7)作为激动剂的效力约为[Sar9]P物质的1/25,而[Sar9]P物质本身的效力又比P物质弱25倍。拮抗剂[D - Arg1,D - Trp7,9,Leu11] - P物质(spantide;1 μM)可显著降低对P物质的反应(n = 8,P < 0.001)。包括CP 99994和GR 82334(均为1 μM)在内的高选择性NK - 1受体拮抗剂在功能和结合研究中均无效。河豚毒素(1 μM)不抑制对P物质、NKA和senktide的收缩反应。总之,本研究表明蟾蜍肠道中存在一种或多种速激肽受体。[125I]BHSP识别的结合位点更倾向于P物质和ranakinin。这种蟾蜍“NK - 1样受体”与哺乳动物NK - 1受体不同,它对所有哺乳动物NK - 1选择性配体(包括拮抗剂)的亲和力都很低。对于一些非哺乳动物肽,它们作为收缩激动剂的高效力与其较差的结合亲和力表明蟾蜍小肠中存在其他速激肽受体。